PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University of Virginiagrid.27755.32, Department of Cell Biology, Charlottesville, Virginia, USA.\', \'University of Virginiagrid.27755.32, Department of Microbiology, Charlottesville, Virginia, USA.\', \'University of Washington, Division of Allergy and Infectious Diseases, Seattle, Washington, USA.\', \'Fred Hutchinson Cancer Research Center, Vaccine and Infectious Diseases Division, Seattle, Washington, USA.\', \'Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.\', \'Institute of Technology, University of Tartu, Tartu, Estonia.\', \'Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.\', \'Oslo Centre for Biostatistics and Epidemiology (OCBE), University of Oslo, Oslo, Norway.\', \'Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.\', \'Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.\', \'MRIGlobal, Gaithersburg, Maryland, USA.\', \'Virology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.\', \'Department of Global Health, University of Washington, Seattle, Washington, USA.\', \'Department of Microbiology, University of Washington, Seattle, Washington, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1128/mbio.03347-21
?:hasPublicationType
?:journal
  • mBio
is ?:pmid of
?:pmid
?:pmid
  • 34933447
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.106
?:rankingScore_hIndex
  • 71
is ?:relation_isRelatedTo_publication of
?:title
  • Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all